US Markets
MS

US STOCKS-Futures fall with focus on jobless claims data

Credit: REUTERS/LUCAS JACKSON

U.S. stock index futures dropped on Thursday as investors braced for weekly jobless claims, which could compound fears of a stalling economic recovery a day after Treasury Secretary Steven Mnuchin dashed hopes for more fiscal aid before the election.

By Medha Singh

Oct 15 (Reuters) - U.S. stock index futures dropped on Thursday as investors braced for weekly jobless claims, which could compound fears of a stalling economic recovery a day after Treasury Secretary Steven Mnuchin dashed hopes for more fiscal aid before the election.

The Labor Department's data is expected to show the number of Americans filing for state unemployment benefits eased to 825,000 last week from 840,000, but still remain at a high level as the labor market struggled to recover from the damage inflicted by the COVID-19 pandemic.

Hopes of another round of fiscal aid to support the U.S. economy's recovery helped fuel Wall Street's recent rally, bringing the S&P 500 and Nasdaq earlier this week to within 2% of their record closing highs from Sept. 2.

Focus is also on corporate America where expectations for third-quarter earnings have improved to a 18.9% drop from a 25.0% tumble forecast on July 1, according to Refinitiv IBES data.

Morgan Stanley MS.N fell 0.8% in premarket trading ahead of its results which would wrap up earnings from major Wall Street lenders. Other companies scheduled to report are Honeywell International Inc HON.N, Charles Schwab Corp SCHW.N and Walgreens Boot Alliance Inc WBA.N.

At 6:19 a.m. ET, Dow e-minis 1YMcv1 were down 280 points, or 0.99% and S&P 500 e-minis EScv1 were down 37.75 points, or 1.08%.

Nasdaq 100 e-minis NQcv1 were down 191 points, or 1.6%, as tech heavyweights such as Apple Inc AAPL.O, Microsoft Corp MSFT.O and Amazon.com Inc AMZN.O shed between 1.6% and 2.5%.

Shares of drug developer Vertex Pharmaceuticals Inc VRTX.O sank 9.4% premarket after it discontinued its trial of a protein deficiency disorder treatment.

(Reporting by Medha Singh in Bengaluru; Editing by Shounak Dasgupta)

((Medha.Singh@thomsonreuters.com; within U.S. +1646 223 8780, outside U.S. +91 80 6182 2802; Twitter: https://twitter.com/medhasinghs))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MS HON SCHW WBA AAPL MSFT AMZN VRTX NDX SPX

Latest Markets Videos

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More